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SUMMARY: Recently, microalgae cultivation for different applications, including the production of nutritional 
and pharmaceutical active compounds has received increasing attention. Among the different genera, Spirulina 
(Arthrospira sp.) is one of the most promising blue-green microalgae (Cyanophyta) because it is rich in antioxi-
dants, essential amino acids (EAAs), minerals, proteins, polyunsaturated fatty acids and vitamins. It has a high 
protein content (60-70% of the dry weight), which is a complete protein, i.e. containing all EAAs. Therefore, 
Spirulina is currently a commercial product with high nutritional value and also a significant source of comple-
mentary and alternative medicine. The objective of the present work was to review the pharmaceutical and 
therapeutic applications of Spirulina, especially its antioxidant, anti-inflammatory, anti-cancer, anti-microbial, 
anti-diabetic, anti-obesity and anti-toxicity properties. The results were obtained from experiments in the litera-
ture performed in vitro and in vivo using experimental animals. The main reported active ingredients in Spirulina 
include phycocyanin, tocopherol, β-carotene, caffeic acids and chlorogenic acid, which showed individual or syn-
ergetic effects. In addition, the present review discusses the future perspectives of genetically modified Spirulina 
as a source for industrial products while producing valuable biomass photoautotrophically. Furthermore, the 
consequent environmental impacts of large-scale cultivation of Spirulina are discussed.
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RESUMEN: Aplicaciones farmacéuticas e impactos ambientales de la Spirulina (Arthrospira). Una visión general. 
Recientemente, el cultivo de microalgas para diferentes aplicaciones, incluida la producción de compuestos 
activos nutricionales y farmacéuticos, está recibiendo una atención cada vez mayor. Entre los diferentes géneros, 
Spirulina (Arthrospira sp.) es una de las microalgas azul-verde más prometedoras (Cyanophyta) porque es rica en 
antioxidantes, aminoácidos esenciales (EAAs), minerales, proteínas, ácidos grasos poliinsaturados y vitaminas. 
Tiene un alto contenido de proteína (60-70% del peso seco) es una proteína completa, es decir, contiene todos los 
EAAs. Por lo tanto, la Spirulina es actualmente un producto comercial con alto valor nutricional y también una 
fuente importante parala medicina complementaria y alternativa. El objetivo del presente trabajo es revisar las 
aplicaciones farmacéuticas y terapéuticas de Spirulina, especialmente propiedades antioxidantes, antiinflamato-
rias, anticancerígenas, antimicrobianas, antidiabéticas, antiobesidad y antitóxicas. Los resultados se obtienen a 
partir de trabajos experimentales realizados in vitro e in vivo utilizando animales de experimentación. Los prin-
cipales ingredientes activos reportados en Spirulina incluyen ficocianina, tocoferol, β-caroteno, ácidos caféicos 
y clorogénico que mostraron efectos individuales o sinérgicos. Además, en la presente revisión se discute las 
perspectivas futuras de la Spirulina genéticamente modificada como fuente de productos industriales, al mismo 
tiempo que se produce una valiosa biomasa fotoautotrófica. Además, se discutieron los impactos ambientales 
consiguientes del cultivo a gran escala de la Spirulina.
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1. INTRODUCTION
Microorganisms have unique characteristics and 
therefore, they are considered good pillars for the 
large-scale production of many useful metabolites. 
Microbial cells have a high area/volume ratio, which 
results in high efficiency of nutrient uptake for the 
biosynthesis of different metabolites through dif-
ferent metabolic pathways. Microalgae are a wide 
group of photosynthetic microorganisms that can 
be isolated from various habitats and can grow effi-
ciently in commercial large-scale raceway ponds or 
photobioreactors (Figure 1), where cells can grow 
on inexpensive nutrient sources to produce valuable 
compounds. Cyanophytes are a group of microal-
gae commonly grown in rice paddies and have a 
positive impact on growth, yield and nitrogen lev-
els of the crop plants (Whitton, 2000). This group 
of microorganisms also known as cyanobacteria, as 
they resemble bacteria in that they are prokaryotes 
and lack the internal structures such as nucleus and 
other organelles found in eukaryotic microalgae. 
From the practical and economical point of view, 
microalgae offer numerous advantages, such as 
high photosynthetic efficiency which results in high 
growth rates, high CO2 mitigation rate, possibility 
for cultivation on arid lands using marine-, fresh- or 
wastewater (Abomohra et al., 2018). 
Although many previous studies focused on dif-
ferent cyanophytes as nitrogen-fixing organisms, 
Spirulina is gaining attention due to its high nutri-
tional value and extensive pharmaceutical appli-
cations (Table 1). The correct identification of a 
certain species is a fundamental requisite for research 
study and/or developmental applications. The genus 
Spirulina has been incorrectly used to describe two 
different genera, Spirulina and Arthrospira. However, 
Stizenberger (1854) and Gomont (1892–1893) clas-
sified the forms with visible septa within the genus 
Arthrospira Stizenberger 1852; while coiled filaments 
with invisible septa were classified as belonging to 
the genus Spirulina Turpin 1829 (Tomaselli, 1997). 
The view of Arthrospira and Spirulina as two sepa-
rate genera has been officially accepted by Bergey’s 
Manual of Systematic Bacteriology (Castenholz, 
1989). The separation between these two genera has 
been repeatedly affirmed on the basis of many other 
characteristics such as cell wall structure, helicity, tri-
chome size, motility, gas vesicles, thylakoid pattern, 
GC analysis and phylogenetically using 16S rRNA. 
Depending on the later, 16S rRNA of two Arthrospira 
strains (PCC 7345 and PCC 8005) and one Spirulina 
strain (PCC 6313) confirmed that the two Arthrospira 
strains form a tight cluster not closely related to the 
Spirulina strain, which supports the separation of 
these two genera (Tomaselli, 1997). Therefore, a 
molecular approach is not only useful for the precise 
identification of a certain species, but it also helps to 
understand the evolutionary relationships occurring 
among various microorganisms. 
Spirulina is a photosynthetic autotrophic organism 
containing the blue pigment phycocyanin as the main 
photosynthetic pigment in addition to the green pigment 
chlorophyll a, which results in the blue-green color of 
the cells. Spirulina is one of multicellular unbranched 
non-heterocystous filamentous microalgae which are 
recognizable by the unique open left-handed helix along 
the entire length of the filament (Figure 2). The fila-
ments are 50-500 µm in length and 2-4 µm wide, com-
posed of only vegetative cells containing gas vacuoles. 
The long size filaments and strong cells allow success-
ful filtration comparing to unicellular microalgae which 
results in the cost-effective harvest of Spirulina com-
pared to other microalgal species. Currently, microalgae 
cultivation takes place in two major cultivation sys-
tems, namely closed photobioreactors (PBR) and open 
ponds. Both approaches have their own advantages and 
disadvantages which were discussed in details by Soni 
et al., (2017). However, Spirulina is mainly reported to 
be grown commercially in open ponds. Recently, new 
hybrid cost-effective techniques such as poly bags can 
also be used to increase algal biomass productivity 
(Soni et al., 2017).
Many microorganisms are used as a massive sus-
tainable resource for bio-pharmaceuticals which can 
be produced by direct extraction or after biomass 
Figure 1. Surface view of a raceway ponds (A) and partial 
view of tubular photobioreactor (B) used for microalgae 
cultivation (Modified from Abomohra et al., 2016).
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Table 1. Some reported applications of Spirulina
Applications/Activity References
Healthy food, forage 
and additives
Jiménez et al., (2003)
Antioxidant Manoj et al., (1992); Miranda et al., 
(1998); Abomohra et al., (2016).
Anti-inflammatory Romay et al., (1998); Vázquez-
Velasco et al., (2014).
Anti-cancer Schwartz and Shklar (1987); 
Schwartz et al., (1988); Liu et al., 
(2000); Subhashini et al., (2004).
Anti-microbial Kokou et al., (2012); Özdemir et al., 
(2004); Santoyo et al., (2006).
Anti-diabetes and 
anti-obesity
Schwartz et al., (1988); Han et al., 
(2006).
Anti-toxicity Shastri et al., (1999); Kim et al., 
(2011); Abdel-Daim et al., (2016); 
Ebaid et al., (2017).
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bioprocessing. During secondary metabolism, micro-
organisms produce special secondary metabolites 
which possess special chemical structures and are 
not critical for the growth of the producing organ-
ism. In general, such metabolites are produced under 
unfavorable conditions in defense against predation, 
herbivory and competition for space. So far, some 
secondary metabolites from different microorgan-
isms were isolated and identified in pure form. For 
example, chlorellin is a fatty acid produced by the 
green microalga Chlorella vulgaris and was first iden-
tified as an active anti-bacterial substance in 1940s 
(Centeno and Ballentine, 1999). On the other hand, 
the limited availability of fossil fuels and their envi-
ronmental issues, especially participation in global 
warming, enhanced the extensive worldwide search 
for new renewable energy sources with combined CO2 
mitigation. Spirulina was discussed as one of microal-
gae capable of producing different kinds of bioenergy 
with high efficiency of CO2 fixation (Sumprasit et al., 
2017; Shao et al., 2018; Rempel et al., 2018), which 
provides the advantage of an eco-friendly utilization 
of Spirulina. The main aim of the present work was 
to provide a critical overview of the current status of 
the pharmaceutical applications of Spirulina, includ-
ing antioxidant, anti-inflammatory, anti-cancer, anti-
microbial, anti- diabetes & obesity and anti-toxicity 
activities. In addition, future perspectives in genetic 
engineering technologies to enhance valuable prod-
ucts from Spirulina were discussed. The present work 
shed light on the environmental impacts of large-
scale cultivation of Spirulina as one of the economi-
cally important microalgae. 
2. NUTRITIONAL VALUE OF SPIRULINA
Compared to other foods, Spirulina shows extraor-
dinary nutritional value as it provides high levels 
of many essential nutrients and minerals (Table 2). 
However, the biochemical composition of Spirulina 
is highly dependent on growth conditions and the 
methods used for harvest and drying. In general, 
Capelli and Cysewski (2010) reported that the amount 
of calcium in Spirulina is 1.8 times higher than that 
in whole milk, total protein is 6.7 times that of tofu, 
iron is 51 times greater than that of spinach and 
β-carotene is 31 times more abundant than in carrots. 
Therefore, Spirulina was given the label of ‘super food’ 
by The World Health Organization (WHO). In addi-
tion, it was sent to space by National Aeronautics and 
Space Administration (NASA) due to its high nutri-
tional value (Khan et al., 2005). Spirulina is produced 
commercially in open ponds by many producers 
(Table 3). Earthrise Farms, located in USA, covering 
437060 m2, is the world’s largest producer of Spirulina. 
The company produces dried Spirulina in the form of 
tablets and powder in over 20 countries around the 
world with an average annual production of 550 tons. 
Other large Spirulina production plants are Cyanotech 
and Hainan DIC Microalgae located in USA and 
China, covering 364217 and 100000 m2 with annual 
production of 400 and 350 tons, respectively (Table 3). 
However, other companies sell Spirulina special prod-
ucts such as nutraceuticals, e.g. Myanmar Spirulina 
Factory (Yangon, Myanmar) sells tablets, chips, pasta 
and liquid extract. 
3.  PHARMACEUTICAL APPLICATIONS OF 
SPIRULINA
Spirulina is the most highly consumed microalga 
(Bleakley and Hayes, 2017), which has been widely 
used as human healthy food centuries ago; and it is 
currently produced commercially as healthy food 
and valued additives in a hugely profitable business. 
In addition to its high nutritional value, Spirulina 
shows many biological activities such as antioxidant, 
anti-inflammatory, anti-cancer, anti-microbial, anti- 
diabetes & obesity and anti-toxicity.
3.1. Antioxidant activities
Spirulina extracts show relatively high anti-
oxidant activities that have attracted the atten-
tion of  many researchers. Manoj et al., (1992) 
confirmed the activity of  alcoholic extract of 
Figure 2. Microscopic examination of Spirulina under light microscope (A, Ebaid et al., 2017) 
and scanning electron microscope (B, Ciferri 1984).
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Spirulina in lipid peroxidation inhibition more sig-
nificantly (65%) than some chemical antioxidants 
like α-tocopherol (35%) and β-carotene (48%). In 
addition, they reported that a hot-water extract 
of  Spirulina has a greater antioxidant effect (76%) 
than chlorogenic acid (56%) and gallic acid (54%). 
Miranda et al., (1998) studied the in vivo and in 
vitro antioxidant activity of  S. maxima methanolic 
extract. In vivo antioxidant activity as lipid peroxi-
dation was studied in the plasma, brain and liver 
homogenates of  experimental rats using a daily 
dose of  5 mg of  methanolic extract. The extract 
contained total tocopherol, β-carotene and total 
phenolic compounds of 18 mg·L–1, 27.5 mg·L–1 
and 96.3 mg·L–1, respectively. Upon treatment, 
the antioxidant activity increased in the plasma 
of  the Spirulina-treated group by 31.5% over the 
control group. The antioxidant effect was mainly 
associated with the individual or synergetic effect 
of  tocopherol, β-carotene and phenolic com-
pounds. In another study, the antioxidant activity 
was attributed to the phenolic compounds found 
in the methanolic alga extract including salicylic, 
chlorogenic, trans- cinnamic, caffeic acids, quimic 
and synaptic; individually or in a synergistic action 
(Baicus and Baicus, 2007). However, the caffeic 
acids and chlorogenic acid present in the Spirulina 
extract recorded more antioxidant efficiency 
than other acids (Henrikson, 1994); which also 
recorded a potential preventive action against can-
cer (Subhashini et al., 2004). Recently, Abomohra 
et al., (2016) concluded that the exposure of  A. pla-
tensis to gamma radiation induces the cellular reac-
tive oxygen species (ROS) by purinergic signaling, 
Table 2. Typical analysis of the composition of Spirulina (per 3 grams of dry biomass, Moorhead et al., 2012)
Items Amount Items Amount
General Composition Phytonutrients
Carbohydrates 17-25% Chlorophyll 30 mg
Protein 53-62% Total carotenoids 15 mg
Lipids 4-6% β-carotene 6.8 mg
Minerals 8-13% Total phycocyanins 519 mg
Vitamins C-phycocyanin 240 mg
Vitamin A 11,250 IU Zeaxanthin 9 mg
Vitamin B1 3.5 µg Superoxide dismutase 1080 units
Vitamin B2 140 µg Minerals
Vitamin B3 400 µg Calcium 10 mg
Vitamin B6 30 µg Magnesium 15 mg
Vitamin B12 9.0 µg Iron 6.5 mg
Vitamin E 285 µg Phosphorus 33 mg
Inositol 1.7 µg Potassium 60 mg
Biotin 0.5 µg Sodium 30 mg
Folic acid 6.2 µg Manganese 400 µg
Pantothenic acid 4.5 µg Zinc 90 µg
Vitamin K1 60 µg Boron 22 µg
Vitamin K2 15 µg Copper 20 µg
Selenium 0.9 µg
Iodine 15 µg
Table 3. Some current commercial producers of Spirulina with annual production of biomass
Company Location Total area (m2) Production (ton)
Earthrise Farms USA 437060 550
Cyanotech USA 364217 400
Hainan DIC Microalgae Co., Ltd China 100000 350
Nao Pao Resins Chemical Co., Ltd Taiwan 50000 150
Boonsom Farm Thailand 40000 -
Siam Algae Co., Ltd. Thailand 30000 135
Solarium Biotechnology Chile 24000 13
Pharmaceutical applications and consequent environmental impacts of Spirulina (Arthrospira): An overview • 5
Grasas Aceites 70 (1), January–March 2019, e292. ISSN-L: 0017–3495 https://doi.org/10.3989/gya.0690181
stimulating cells to produce more antioxidants 
under the induced oxidative stress.
3.2. Anti-inflammatory activities
The light-harvesting pigment “phycocyanin” is one 
of phycobiliproteins along with phycoerythrin and 
allophycocyanin, and found exclusively in cyanobac-
teria, cryptophytes and red algae (Hu et al., 2018). 
The presence of phycocyanin gives the characteristic 
blue color of cyanophytes, and hence the name of blue 
green algae. Eriksen (2016) concluded that Spirulina is 
the sole efficient source of natural phycocyanin pro-
duction under photoautotrophic conditions. Despite 
the challenges facing Spirulina cultivation and phyco-
cyanin extraction, there are no other particular sources 
of natural phycocyanin (Hu et al., 2018). In addition 
to the autotrophic growth of Spirulina, it is also capa-
ble of heterotrophic growth in the presence of glucose, 
with a phycocyanin content of 57 mg·g−1 dry weight, 
which represents half of that obtained in mixotrophic 
cultivation (Marquez et al., 1993). Phycocyanin can 
also be produced from other microalgae, e.g. from the 
unicellular red alga Galdieria sulphuraria under hetero-
trophic conditions. However, the phycocyanin content 
in Spirulina grown phototrophically is much higher 
than that of G. sulphuraria grown heterotrophically 
(Table 4), which gives the advantage of a lower cost 
production of phycocyanin using Spirulina. 
In a previous study, Ebaid et al., (2017) estimated 
the phycocyanin content of 46.57 mg·g−1 dry weight in 
A. platensis grown in a Zarrouk medium for 18 days at 
25 ± 3 °C and light intensity of 2500 Lux with a photo-
period of 18:6 h light: dark cycle. It is worth noting that 
the relative content of phycocyanin showed significant 
changes under different conditions of prevalent light, 
which was confirmed as a scavenging mechanism to 
prevent or reduce photoinhibitory damage (Mohanty 
et al., 1997). Romay et al., (1998) studied four in vivo 
experimental inflammation models (n = 7) and con-
firmed the activity of pure phycocyanin as an anti-
inflammatory agent in all the studied models. Using 
50, 100 and 200 mg·kg−1 of phycocyanin significantly 
reduced ear oedema induced by tetradecanoylphor-
bol acetate and arachidonic acid in mice by 47.6, 60.3 
and 66.6%, respectively. In addition, the application 
of  50-200 mg·kg−1 of phycocyanin in experimental 
rats inhibited leukotriene B4 (LTB4), prostaglandin E2 
(PGE2) levels and oedema induced by arachidonic acid 
(Romay et al., 2000). Vázquez-Velasco et al., (2014) 
concluded that Spirulina protects against negative 
proinflammatory effects induced by glucomannan in 
Zucker Fa/Fa rats due to the high phycocyanin content. 
3.3. Anti-cancer activities
Many cancer forms result from cellular DNA 
damage, leading to uncontrolled cellular growth. 
Cellular endonucleases frequently repair the 
damaged DNA in order to keep the cell alive and 
healthy. The deactivation of these enzymes by oxi-
dation, radiation or toxins results in errors in DNA, 
and eventually leads to the development of cancer. 
Many studies confirmed the anti-cancer activities 
of  Spirulina extracts, either alone or in combination 
with other compounds. In vitro studies suggested the 
unique composition of Spirulina polysaccharides 
which enhance enzymatic activity and DNA repair. 
Decades ago, Schwartz and Shklar (1987) studied 
the effect of  microalgae extracts on the induced 
squamous cell carcinoma of hamster buccal pouches 
in 20 animals. The results showed that Spirulina 
extract (Phycotene) resulted in total tumor regres-
sion by 30% of treated animals; while β-carotene and 
canthaxanthin resulted in total tumor regression 
by 20% and 15% of treated animals, respectively. 
This confirmed the higher anti-cancer activity of 
Spirulina extract than β-carotene or canthaxanthin. 
One year later, Schwartz et al., (1988) reported that 
the anti-cancer activity of the Spirulina extract was 
attributed to stimulation of the immune response 
to selectively destroy the small foci of  developing 
malignant cells with no negative impacts on the nor-
mal cells. Liu et al., (2000) found that 160 mg·L−1 of 
c-phycocyanin from S. platensis significantly inhib-
ited the in vitro growth of human leukemia K562 
cells as colony numbers reduced from 4.8 in the con-
trol to 2.3 in the phycocyanin-treated cells after 12 
days of incubation. In addition, Subhashini et al., 
(2004) reported that treatment with 50 µM of highly 
purified c-phycocyanin from S. platensis up to 48 
h results in the inhibition of K562 cell prolifera-
tion by 49%. In another in vivo study, Simsek et al., 
(2008) suggested that S. platensis supplementation 
is useful in the treatment of anemia and leukemia 
induced by lead and cadmium toxicity. Moreover, 
Choi et al., (2013) investigated the anti-cancer activ-
ity of the marine cyanophyte S. maxima grown in 
deep seawater and reported effective suppression in 
the over-expression of the Bcl2 gene in A549 cells 
leading to the inhibition of various human cancer 
cells.
3.4. Anti-microbial activities 
A large number of algal extracellular products 
and/or extracts have been reported as antimicrobial 
(anti-viral, anti-bacterial, anti-fungal, anti-algal, 
anti-protozoal) agents, although the detailed struc-
ture and identity of the active constituents of many of 
these are not yet known (Borowitzka 1995). Among 
microalgae, Spirulina is gaining more and more con-
sideration as a natural antimicrobial agent. Kokou 
et al., (2012) confirmed the anti-bacterial activity of 
Spirulina against 6 Vibrio strains; V. anguillarum, 
V. splendidus, V. parahaemolyticus, V. scophthalmi, 
V.  lentus and V. alginolyticus. The anti-microbial 
activity of acrylic acid, which is found in Spirulina in 
6 • W. Shao et al.
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relatively high quantities, was confirmed at the end 
of 1970s. In addition to acrylic acid, probionic, ben-
zoic, and mandelic organic acids were also reported 
as antimicrobial active compounds. Özdemir et al., 
(2004) also tested different extracts of S. platensis 
against bacteria and yeasts. They found that meth-
anol extract was the most potent anti-microbial 
fraction. Santoyo et al., (2006) confirmed the anti-
microbial activity of S. platensis using ethanol, 
hexane and petroleum ether as extracting solvents 
against Escherichia coli, Staphylococcus aureus, 
Aspergillus niger and Candida albicans. Moreover, 
purified c-phycocyanin extracted from S.  platensis 
showed substantial inhibition in the growth of 
many  multidrug-resistant bacteria. For example, 
purified c-phycocyanin showed minimum inhibi-
tory concentrations (MIC) in vitro of  125, 100, 75 
and 50 mg·L−1 against S. aureus, E. coli, Klebsiella 
pneumonia and Pseudomonas aeruginosa (Sarada 
et al., 2011).
In addition, Arun et al., (2012) confirmed the 
antifungal activity of S. platensis methanolic extract. 
According to Hayashi et al., (1993), S. platensis 
water-soluble extract also significantly inhibited the 
in vitro HSV−1 replication in HeLa cells with ED50 
(the lowest phycocyanin concentration for reduc-
ing plaque number by 50%) at 0.173 mg·mL−1. The 
addition of 1 mg·mL−1 of S. platensis extract 3 h 
before viral infection resulted in 50% inhibition of 
virus protein synthesis without affecting the host. 
Subsequently, Hayashi et al., (1996) isolated calcium 
spirulan (Ca-SP) from S. platensis as a novel sulfate 
polysaccharide. The isolated Ca-SP inhibited the in 
vitro replication of several enveloped viruses such as 
the human cytomegalo virus, HSV−1, influenza A 
virus, measles virus, HIV−1 virus and mumps virus. 
3.5. Anti-diabetes and anti-obesity activities
The disease diabetes mellitus results from abnor-
malities in carbohydrate metabolism and is charac-
terized by deficiencies in insulin secretion, resulting 
in hyperglycemia. The later was widely reported 
as the main reason for diabetic complications. 
Recently, the activity of Spirulina as anti-obesity 
and anti-diabetes was confirmed. The administra-
tion of 2 g·kg-1·day-1 of Spirulina for 21 days to 
alloxanized-induced diabetic rats (n = 10) resulted 
in a significant reduction in plasma glucose levels by 
13.7% below the diabetic group (El-Desouki et al., 
2015). They attributed the antihyperglycemic action 
of Spirulina to the potentiation of the pancreatic 
secretion of insulin from islet β-cells, or to enhance-
ment of blood glucose transport to the peripheral 
tissue. In addition, Spirulina supplementation pro-
motes vasodilation and restricts vasoconstriction 
which decreases the levels of plasma lipids and 
reduces blood pressure (Schwartz et al., 1988). Han 
et al., (2006) reported that glycolipid H-b2 extracted 
from Spirulina was found to reduce postprandial tri-
glyceride (TGs) levels and inhibit pancreatic lipase 
activity in a dose-dependent way; while phycocya-
nin inhibited the pancreatic lipase activity, which 
resulted in higher excretion of TGs in experimental 
animals’ feces and reduced serum TGs.
3.6. Anti-toxicity activities
Shastri et al., (1999) investigated the protective 
effect of S. fusiformis against lead toxicity in albino 
mice and recorded a pronounced increase in sur-
vival rate by administration of Spirulina. Recently, 
Ebaid et al., (2017) studied the protective effect of 
A.  platensis against liver toxicity produced by treat-
ment with copper nanoparticles. They confirmed 
the beneficial role of A. platensis as antioxidant 
markers which enhanced the hepatic functional 
parameters. Numerous mechanisms of cellular 
toxicity induction under stress conditions were 
suggested. Lipid peroxidation is one of the main 
mechanisms to induce cell damage due to the reac-
tion of free radicals with lipids (Rajesh and Kala 
2015). It results in malondialdehyde (MDA), which 
leads to oxidative stress by further interaction with 
many other molecules. Nigma et al., (1999) attrib-
uted ROS production under copper stress to antiox-
idant depletion or the direct effect of copper on the 
peroxidation reaction. However, Kim et al., (2011) 
Table 4. Comparison of heterotrophic cultivation of Galdieria sulphuraria and phototrophic cultivation of Spirulina for 
phycocyanin production (Hu et al., 2018).
Microalgae Carbon source(g·L−1) Growth mode Phycocyanin content Reference
G. sulphuraria 074G Glucose (50) Heterotrophic 3.6 mg/g Schmidt et al. (2005)
G. sulphuraria 074G Fructose (50) Heterotrophic 3.4 mg/g Schmidt et al. (2005)
G. sulphuraria 074G Sucrose (50) Heterotrophic 4.3 mg/g Schmidt et al. (2005)
G. sulphuraria 074G Glucose (500) Heterotrophic 1.4–2.9 g/L Graverholt and Eriksen (2007)
G. sulphuraria 074G Glucose, fructose, glycerol (5) Heterotrophic 2–4 mg/g Sloth et al. (2006)
G. sulphuraria 074G Glucose (5) Heterotrophic 25–30 mg/g Sørensen et al. (2013)
S. platensis UTEX 1926 Glucose (2.5) Phototrophic 322 mg/L Chen et al. (1996)
S. platensis UTEX 1926 Acetate (2) Phototrophic 246 mg/L Chen et al. (1996)
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reported that ROS alter various signal-transduction 
pathways in addition to the oxidation of vital cel-
lular macromolecules such as DNA and lipids. ROS 
also increases the cytosolic Ca+2 levels by activation 
of non-selective cation channels in cell membranes 
(Mukherjee et al., 2002), promoting cell damage. 
The protective effect of Spirulina against oxidative 
stress was attributed to the relatively high contents 
of phycocyanin and carotenoids which result in 
antioxidant activity (Ebaid et al., 2017). In addition, 
S. platensis was found to positively influence the 
antioxidant enzyme level and oxidative stress mark-
ers under deltamethrin toxicity (Abdel-Daim et al., 
2016), urethane and cisplatin (Premkumar et  al., 
2004) and mitomycin C and cyclophosphamide 
(Premkumar et al., 2001). In addition to its anti-
oxidant properties, Spirulina showed a strong heavy 
metal chelating activity which reduced its toxicity as 
well (Rangsayator et al., 2002).
4. ENVIRONMENTAL IMPACTS
The scarcity of clean environments for the safe 
livelihood of human beings has gained global con-
cerns. Continuous growth of the human population 
has resulted in an increase in petroleum consump-
tion and growing energy demands all over the world. 
Due to human population growth, the world energy 
consumption is predicted to grow by 8.1% between 
2015 and 2040, from 97.8 quadrillion British ther-
mal units (Btu) to 105.7 quadrillion Btu (Fig. 3A). 
The extensive use of fossil fuels contributes to high 
atmospheric CO2 levels, which are predicted to 
increase by 2.2% between 2015 and 2040 (Figure 
3B). Increases in atmospheric CO2 raise the global 
air temperature, which is known as “global warm-
ing”. If  this development continues, the planet will 
be threatened with the catastrophic changes in the 
earth’s climate. Global warming does not only mean 
the earth’s getting warmer, but it is associated with 
massive negative impacts on economic, social, and 
physical health which are of great distress. The 
melting of polar ice, violent surges of hurricanes 
and collapse of wildlife are all examples of how cli-
mate change can affect the planet. Microalgae are 
widely discussed to diminish the greenhouse effect 
by CO2 sequestration and abundant oxygen produc-
tion. A stoichiometric amount of 1.8 kg CO2·kg
−1 of 
microalgal biomass can be consumed which makes 
Spirulina cultivation using flue gas more economi-
cally and environmentally useful (Doucha et  al., 
2005). Based on the biomass produced by the area of 
Earthrise Farms (550 tons in 0.437 km2), about 990 
tons of CO2 can be mitigated annually by Earthrise 
Farms. Thus, 28.9% of USA land area would be 
theoretically used to mitigate the global CO2 pro-
duced in 2015, which could be increased to 29.5% 
by the expected increase in CO2 emission in 2040 
(Figure  3B). In addition, environmental pollution 
might result from the corruption of human resources 
by various micropollutants including pharmaceuti-
cal contaminants (Xiong et al., 2018). The distribu-
tion of these synthetic chemicals through the air, 
water and soil develop multidrug-resistant micro-
organisms. Therefore, the use of naturally synthe-
sized products with the limitation of using chemical 
compounds will enhance the optimal utilization of 
pharmaceuticals. 
Water and land use are two important environmen-
tal factors that need to be considered. Interestingly, 
Spirulina cultivation can be done in arid lands where 
no  other crops can survive (Soni et al., 2016). In addi-
tion, it needs relatively lower amount of water, as water 
can be recycled after harvest. After the extraction of 
essential compounds from the biomass, the residual 
biomass can be used in many other applications in 
what is called refining process (Figure 4). For example, 
sugar-based and cellulosic biorefining results in the 
accumulation of protein by-products, which can be 
used as animal feed (Soni et al., 2016). In addition, after 
the extraction of essential compounds, the residual 
biomass can be used as energy feedstock for biodiesel 
production from lipids and/or bioethanol production 
from carbohydrate residues. Thus, integrated food and 
energy systems are designed to combine, intensify, and 
increase the productivity of food and energy simulta-
neously through sustainable land management (Soni 
et al., 2016). Using Spirulina as bioenergy feedstock 
showed promising results in many studies. Sumprasit 
et al., (2017) studied energy recovery in the form of 
biodiesel and biogas from ubiquitous S. platensis and 
recorded a biodiesel yield of 7.1% of dry weight. The 
results also confirmed that lipid-free residue can be 
used as feedstock for biogas production with an aver-
age methane yield of about 290 mL·g−1 VS. In addition, 
Shao et al., (2018) reported the efficiency of Cd2+-
sorbed Arthrospira platensis for bioethanol production 
due to the accumulation of carbohydrates. Moreover, 
Chagas et al., (2016) studied the catalytic pyrolysis of 
Arthrospira platensis and Arthrospira maxima using 
pyrolysis/GC–MS. They found that the high acidity of 
HZSM-5 catalysts could maximize the conversion of 
biomass to aromatic hydrocarbons and the aromatic 
yields increased as the catalyst/biomass ratio increased 
from 1:1 to 10:1.By food-energy integration, Spirulina 
products are even more economically competitive with 
high diversification. Consequently, large-scale cultiva-
tion of Spirulina will not only have healthy and eco-
nomic benefits, but will also help to save our planet. 
5. GENETIC ENGINEERING OF SPIRULINA
Genetic engineering facilitates the duplication 
and manipulation of specific fragments of DNA for 
industrial, medical and research purposes. Recently, 
genetic engineering led to a revolution in molecu-
lar biology with many benefits in different fields, 
especially in medicine. The cloning of recombinant 
8 • W. Shao et al.
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DNA facilitates the use of bacteria to produce 
important proteins such as human insulin which is 
of great importance and now marketed throughout 
the world. It was revealed that biosynthetic path-
ways for the production of different cellular mac-
romolecules are complex processes which include 
many genes (Bhunia et al., 2018). Many industrial 
compounds can be produced by several molecular 
techniques such as rational and non-rational muta-
genesis, including site-specific mutagenesis, random 
mutagenesis, and site-saturation mutagenesis. In 
the last few decades, extensive research has been 
carried out to understand the biosynthesis genetic 
regulations of different valuable products in cyano-
phytes. For example, enhanced alcohol production 
via genetic engineering has been implemented in 
two independent cyanobacterial strains through the 
over-expression of pyruvate decarboxylase and alco-
hol dehydrogenase II genes (Deng and Coleman, 
1999). In addition, previous studies on the regula-
tion of desaturase gene expression in Spirulina pla-
tensis revealed that the mRNA level and mRNA 
stability of the D6D gene increased drastically by 
decreasing the growth temperature from 35 to 22 °C, 
which led to an increase in the cellular γ-linolenic 
acid level by approximately 30% (Deshnium et al., 
2000; Honsthong et al., 2003). Further, site-specific 
mutation studies by Subudhi et al., (2008) demon-
strated that the sequence TATAAT located at −33 
bp was essential for the D6D promoter function 
and suggested a complex regulation of D6D gene 
expression in Spirulina.
Currently, most cloned genes are introduced into 
bacteria or fungi on heterotrophic growth media for 
industrial enzyme production. However, developing 
a protocol for using Spirulina instead involves an eco-
nomic and procedural reason for considering it as an 
alternate producer of industrial enzymes. Spirulina 
Figure 3. Current and predicted global population and total energy consumption (A) and global CO2 emission as a result of fuel 
combustion with the estimated USA area required for global CO2 mitigation (B). Data in part was calculated from “Global Energy 
Statistical Yearbook 2015”.
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can grow autotrophically by converting light energy 
into biomass rich in minerals, protein, vitamin B12, 
essential fatty acids, amino acids and β-carotene. In 
addition, Spirulina does not require physical or chem-
ical pre-treatment in order to become digestible due 
to the absence of a cellulosic cell wall (Toyomizu et al., 
2001a). Moreover, residual biomass after the extrac-
tion of valuable molecules can be used as feed for fish, 
farm animals and poultry (Toyomizu et al., 2001b; 
Abomohra et al., 2014). Therefore, the development 
of a method for stable gene cloning into Spirulina 
as a biological factory for recombinant enzyme pro-
duction will have many advantages. Unfortunately, 
the genetic engineering methods for Spirulina have 
been almost non-existent due to the absence of 
plasmids in Spirulina (Vachhani and Vonshak, 1997; 
Toyomizu et al., 2001a). Some Spirulina platensis 
genes involved in fundamental processes such as pro-
tein synthesis, carbon dioxide fixation and nitrogen 
metabolism were successfully cloned (e.g. Bini et al., 
1992; Nelissen et al., 1994; Murata et al., 1996). 
However, the development of gene transfer systems 
is a big challenge. Using the plasmid pKK232–8 car-
rying a promoterless chloramphenicol acetyltrans-
ferase (CAT) gene, Cheevadhanarak et al., (1993) 
transformed S.  platensis to stably express the CAT 
gene which maintained under selection pressure for 
several generations. However, the stability of the 
transformants was a major problem, as the transfor-
mation system developed for Spirulina must be effi-
cient and allow not only a good degree of expression 
of the introduced gene but also to maintain itself  
in a fast-growing culture. Toyomizu et al., (2001a) 
studied the optimization of electroporation of plas-
mid pHSG399 in S. platensis. The plasmid contained 
a chloramphenicol resistance gene which produces 
an E. coli protein, Cm acetyltransferase (CAT). 
They reported that Spirulina is a suitable organism 
for the expression of genetically engineered proteins, 
but the gene transfer system has not yet been estab-
lished. Later, Kawata et al., (2004) employed a new 
approach using natural transposase, mini-Tn5 trans-
poson, and a cation liposome to transform Spirulina 
platensis as a stable recombinant DNA methodol-
ogy. According to Toyomizu et al., (2001a), more 
research is needed to investigate other requirements 
for a ‘stable’ S. platensis gene transfer system, which 
include; (1) cloning and assessment of Spirulina pro-
moters using a plasmid carrying a promoterless CAT 
reporter gene, (2) developing a simple and rapid 
method for sensitive fluorometric determination of 
Spirulina transformants, and (3) subjecting Spirulina 
transformants to protoplast fusion in glycine, for 
cloning. Thus, genetic engineering techniques cur-
rently used in plant and microbial biotechnology are 
required to enable Spirulina, as an autotrophic fac-
tory, to produce desired molecules in order to incor-
porate algal biotechnology products into industrial 
technologies.
6. CONCLUSIONS
Spirulina is considered as a valuable pharmaceu-
tical agent which offers many unique features with 
many environmental and health benefits. Despite their 
extensive applications for nutrition, the industrial 
Figure 4. Illustration showing the refining concept and different pathways of Spirulina 
applications.
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production of Spirulina is still more or less limited 
to relatively small areas. In addition, the molecu-
lar engineering of Spirulina seems as a neglected 
research field in spite of its importance to resolving 
many challenges, and any piece of work accumu-
lated at this stage will be undoubtedly of great value. 
There is much more research which needs to be done, 
including innovative cultivation systems and devel-
opment of successful genetic and molecular biology 
tools for Spirulina. The development of a reliable 
genetic engineering methodology will open the way, 
not only for better basic research, but also will enable 
a better program for the development of new and 
better strains to be used by the industry. This could 
integrate Spirulina into the industrial sector for the 
production of essential industrial products while pro-
ducing valuable nutrient-rich biomass. In addition, 
nutritional awareness and increasing the acceptance 
level of Spirulina are required in order to develop 
such Spirulina-fortified products. At the same time, 
further scientific, clinical and toxicological research 
is required to evaluate the safety of large-scale pro-
duction of Spirulina with harvest at minimum con-
tamination rates, since contamination with harmful 
elements or toxic substances might potentially cause 
several serious human health effects.
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